Miguel Regueiro, MD, on Understanding Side Effects: Ensuring Proper Drug Monitoring in IBD

 

 

Dr Miguel Regueiro from Cleveland Clinic discusses different biologic therapeutics for IBD and why it is important for gastroenterologists to know and understand potential side effects for drug monitoring.

Miguel Regueiro, MD, is the Chair of the Department of Gastroenterology, Hepatology & Nutrition and Vice Chair of the Digestive Disease and Surgery Institute at Cleveland Clinic in Ohio.

For more content on gastroenterology, visit our specialty site Gastroenterology Consultant.

 

Published in partnership with Advances in Inflammatory Bowel Disease

Submit Feedback

Name